Markets

Cencora Inc

stock
COR· NYSE· Health Care

325.06

+1.21 (+0.37%)

Price as of 13 Oct, 11:56 · Rate limit reached. Please try again in a minute.

1 Sept8 Sept14 Sept18 Sept24 Sept30 Sept6 Oct12 Oct300310320330340
67

Good Money Guide Pro Score

Attractive

Attractive investment profile

Technical Analysis

Short-Term Outlook

Neutral

2 bull · 2 bear · 1 neutral

Medium-Term Outlook

Bullish

4 bull · 0 bear · 0 neutral

Moving Average (50d)
Bullish
318.87

Price above 50-day MA

Moving Average (200d)
Bullish
317.50

Price above 200-day MA

EMA (12d)
Bullish
319.15

Price above 12-day EMA

EMA (26d)
Bullish
317.32

Price above 26-day EMA

RSI (14)
Neutral
64.4

Neutral momentum zone

MACD
Bullish
1.83

MACD above signal line

Stochastic Oscillator
Bearish
99.5%

Overbought — potential reversal down

Bollinger Bands
Bearish
313.86

Price near upper band — potential reversal

Standard Deviation
Neutral
7.45

Volatility measure — informational only

Volume Indicators

On Balance Volume (OBV)

29 Jul12 Aug27 Aug11 Sept28 Sept05.5M11.0M22.0M

Volume Accumulation Distribution (VAD)

29 Jul12 Aug27 Aug11 Sept28 Sept06.5M13.0M26.0M

Market Statistics

Day Change

+1.21

Market Cap

59905348000

Exchange

NYSE

Sector

Health Care

Fundamentals

Rate limit reached. Please try again in a minute.

Analyst Forecast

Rate limit reached. Please try again in a minute.

Fundamental Analysis

Unable to load fundamental data

Learn about Cencora Inc

What is Cencora Inc?

Cencora Inc, formerly known as AmerisourceBergen, is a leading global pharmaceutical sourcing and distribution services company. It acts as a crucial link in the healthcare supply chain by connecting pharmaceutical manufacturers with healthcare providers, such as pharmacies and hospitals, to ensure patients receive essential medications. The company also offers specialized services to help drug manufacturers bring new treatments to market efficiently.

Is Cencora Inc a good investment?

Cencora benefits from a consistent demand for healthcare products, providing it with relatively stable revenue streams and a strong market position. However, investors should be aware of risks such as razor-thin profit margins, intense industry competition, and ongoing legal complexities surrounding the distribution of controlled substances. Please remember that this overview is for educational purposes only and does not constitute financial advice.

How do you invest in Cencora Inc?

You can invest in Cencora by purchasing its shares directly through a brokerage account using the ticker symbol COR. Alternatively, you can gain indirect exposure to the stock by investing in healthcare-focused mutual funds or exchange-traded funds (ETFs) that include Cencora as a holding. Ensure you research your broker's fees and trading requirements before opening a position.

Educational content generated by AI — not financial advice.

Time & Sales

No trades yet.

News & Sentiment

Rate limit reached. Please try again in a minute.

Share your opinion

Log in or sign up to share your opinion.

Sign up

Community Discussion

No posts yet for COR — be the first to start the discussion.

Trade

Log in or sign up to place simulated trades.

Sign up

Point & Figure Analysis

OHLC

O: 317.30
H: 322.41
L: 315.15
C: 317.25
V: 1,060,700

Signals

as of 07 Oct 2026
TrendConsolidation
RelativeBull ▲
Strength
Last Climax (SELL)(06 May 2026)
Last KDR (BOUNCE)(07 Oct 2026)
Last POS (REVERSAL)(30 Sept 2026)
Last MA Crossover(GOLDEN) 29 Jul 2026

Targets

No active targets — trend is consolidating.

© 2026 Good Money Guide Pro. All rights reserved.

All content copyright Good Money Guide Pro. Good Money Guide Pro is a registered trademark and is owned and operated by RJBCO Ltd. Registered in England & Wales, Company Number: 07134687. Registered office at 11 Old Bond Street, Mayfair, London W1S 4PN. VAT registration number: 324242143. Data protection registration number: ZA468875.

The information contained in this website is for informational purposes only and does not constitute financial advice. The material does not contain (and should not be construed as containing) investment advice or an investment recommendation, or, an offer of or solicitation for, a transaction in any financial instrument.